The Peter Attia Drive - July 27, 2020


#121 - Azra Raza, M.D.: Why we're losing the war on cancer


Episode Stats

Length

1 hour and 54 minutes

Words per Minute

156.28885

Word Count

17,933

Sentence Count

990

Misogynist Sentences

6

Hate Speech Sentences

12


Summary

Dr. Azra Raza is a Professor of Medicine and the Director of the MDS Center at Columbia University in New York. She is a practicing oncologist and a cancer researcher who has been published in over 300 peer review manuscripts. She grew up and attended medical school in Pakistan before moving to the United States for her clinical training. She s an expert in Myelodysplastic syndrome, which is a form of pre-leukemia and acute myeloid leukemia, AML. She's a recipient of a number of awards, including the 2012 Hope Award in Cancer Research, which she shared with Nobel Laureate, Dr. Elizabeth Blackburn. Dr. Raza has been an outspoken advocate for completely reconfiguring the current model of research in cancer, and the purpose of this episode is to dive into her beautiful book, The First Cell, which really is a completely critical look at how medical research is using the wrong types of models.


Transcript

00:00:00.000 Hey everyone, welcome to the drive podcast. I'm your host, Peter Atiyah. This podcast,
00:00:15.480 my website and my weekly newsletter all focus on the goal of translating the science of longevity
00:00:19.800 into something accessible for everyone. Our goal is to provide the best content in health and
00:00:24.760 wellness full stop. And we've assembled a great team of analysts to make this happen.
00:00:28.880 If you enjoy this podcast, we've created a membership program that brings you far more
00:00:33.280 in-depth content. If you want to take your knowledge of the space to the next level at
00:00:37.320 the end of this episode, I'll explain what those benefits are. Or if you want to learn more now,
00:00:41.720 head over to peteratiyahmd.com forward slash subscribe. Now, without further delay, here's
00:00:48.080 today's episode. My guest this week is Dr. Azra Raza. Dr. Raza is a professor of medicine and the
00:00:56.600 director of the MDS Center at Columbia University in New York. She is a practicing oncologist and
00:01:02.540 a cancer researcher who has been published in over 300 peer review manuscripts. She grew up and
00:01:07.900 attended medical school in Pakistan before moving to the United States for her clinical training,
00:01:11.500 which we discuss briefly. She's an expert in myelodysplastic syndrome, which is a form of
00:01:16.740 pre-leukemia and acute myeloid leukemia, AML. She's a recipient of a number of awards, including the 2012
00:01:24.420 Hope Award in cancer research, which she shared with Nobel laureate, Dr. Elizabeth Blackburn. Dr.
00:01:30.360 Raza is an outspoken advocate for completely reconfiguring the current model of research in
00:01:36.320 cancer. And the purpose of this discussion is really to dive into her beautiful book, The First
00:01:42.360 Cell, which really is a completely critical look at how medical research is using the wrong types of
00:01:52.140 models. My words, not hers. The ROI on spending is completely out of line with what anybody would
00:01:59.340 consider reasonable if they were to consider it from an objective lens. And frankly, we end with
00:02:04.520 what I think is a very thoughtful discussion around what the way forward looks like, because you could
00:02:09.300 easily get through this. And I always love to speak with a person a little bit before and a little
00:02:12.240 bit after. And at the end, she said, you know, gosh, I really, I hope we didn't get too much onto a
00:02:15.940 down note. And I said, no, I don't think we did. I think that there's enough sort of hype around
00:02:20.600 cancer research that it's okay to lift the sheets a little bit and show this side of things.
00:02:25.060 A couple of things I'd say about this episode. First of all, Azra goes out of her way, both in
00:02:28.840 the book and if you hear her in other interviews to say, look, this is not someone who considers
00:02:32.760 herself a writer. This is a person who considers herself both a physician and a scientist. And in
00:02:37.560 many ways sort of wrote this book because she just really needed to talk about this stuff.
00:02:41.000 To which I would say, one, it's very beautifully written, but two, I was blown away at the
00:02:45.780 literary sprinklings that made their way into this. I mean, and you have to remember, we're doing this
00:02:51.400 by Zoom basically, or a comparable platform. So we can look at each other on video. And just as sure
00:02:57.880 as I'm looking at another person across from the table, I would ask her a question and she would
00:03:01.800 respond by quoting Emily Dickinson. And not just quote it like I've memorized this, but quote it in
00:03:07.660 the most lyrical way. So I think if you're a fan of literature, science, you have an interest in
00:03:13.380 oncology. There are a lot of things you'll get out of this episode. So I'll leave it at that.
00:03:18.080 And I hope that you do enjoy my conversation with Dr. Azra Raza.
00:03:27.360 Azra, thank you so much for not just making time to be here today, but as you told me before we
00:03:33.500 started setting aside a lot of time, it's an honor to sit with you. I've known a little bit about you
00:03:39.380 before your book was published because one of my colleagues knew about you and said, hey,
00:03:45.320 this is an amazing woman who's in the process of writing an amazing book. And you're definitely
00:03:50.360 going to want to not only read it, but more importantly, I think, speak with her and be
00:03:55.000 able to interview her and talk more broadly about this subject matter. And it's hard to believe that
00:03:59.060 that was probably a year ago, if not more. You're an oncologist by training. And I've seen a couple of
00:04:06.540 your short interviews, though I've gone out of my way to not listen to you on previous podcasts,
00:04:10.960 who is not color how I want to talk with you. But the two times I've seen you on very short clips on
00:04:16.980 YouTube, you've made it very clear that you are not a writer, which I find ironic given how well you
00:04:22.820 write. So at what point did you decide that a book was an appropriate tool to communicate the amazing
00:04:34.180 ideas that we're going to spend a lot of time getting into?
00:04:38.020 Thank you, Peter, for having me on your podcast. I have been an admirer of your work and of the kind
00:04:46.740 of wellness philosophy that you propose, you belong to, you practice, you propagate, you promote. I love
00:04:56.020 it all. And the number of things you do is very admirable. So it's really a pleasure to be on your
00:05:02.620 podcast. I have to tell you that Dorothy Parker once said that if one of your friends come to you,
00:05:10.200 and they say they want to write a book, the second biggest favor you can do them is give them a copy
00:05:17.220 of the Elements of Style by Strunk and White. And of course, the first favor is kill them immediately.
00:05:23.400 So I knew all along that I'm never going to write a book because I'm going to, I'm a big admirer of
00:05:32.600 Dorothy Parker. And then what happened, Peter, is that one of my dear friends in New York who happens
00:05:38.520 to be a literary agent, John Brockman, and his wife Katinka would often talk to me and say,
00:05:46.020 Ezra, how about writing a book? And I would say, no, I'm not a writer. And they would say, well,
00:05:49.880 you're haranguing us with the same things for 10 years. All that is wrong. You want to do something,
00:05:55.820 you want to change the field, write a book. I will get it published. And I would keep saying, no,
00:06:02.080 until I had a course as an oncologist, number one, after 30 years of being in the field,
00:06:10.740 I had a little bit to say. But then the second thing is that I've also been a basic science
00:06:17.140 researcher. I've had a very active lab all along. And my third credential is that I'm a cancer
00:06:23.020 widow. So I have experienced oncology from all three perspectives. As an oncologist who sees 30
00:06:32.800 to 40 patients a week for the last 30 plus years, as a basic researcher who's had a well-funded lab for
00:06:41.320 35 years. And as someone who stood on both sides of the bed at the same time of a cancer patient,
00:06:48.260 who was the love of my life. So even these credentials, Peter, were not sufficient to motivate
00:06:56.980 me to write the book. What did it was my daughter Shahrazad's best friend since 15 years of age,
00:07:03.580 not her boyfriend, her best friend, who's gay, Andrew, at 22 years of age, finds the field's weakness
00:07:12.360 in his arm and taken to the emergency room. He's quadriplegic within hours, and he's found to have a
00:07:18.060 nine centimeter large brain tumor, which was unresectable. And pathology showed that it is
00:07:25.400 one of the most malignant tumors ever known to mankind, glioblastoma multiforme.
00:07:31.360 When this boy opened his eyes, and he stole his diagnosis, the first thing he told his mother,
00:07:38.160 Peter, was, Mom, don't worry, just call Asra. She's on the cutting edge, she will cure me.
00:07:44.740 So here I am, it slapped me in the face physically, that on the one hand, the ferociousness and violence
00:07:53.820 of his tumor. And on the other hand, the utter helplessness of all of us, his oncologists,
00:08:02.460 to do anything about it. Our complete failure in front of Andrew. How is it possible that we are
00:08:10.020 so spectacularly failing a 22-year-old boy? That's what forced me to write the book.
00:08:16.900 Someone once said, and I'm sure it's been paraphrased, and so I won't attribute it because
00:08:21.540 I don't know where it came from, but the only reason to write a book is if you absolutely can't
00:08:27.200 not write it. And it sounds like that's sort of where you were after all of the things that you've
00:08:33.160 described, which is not only losing Harvey, which I think he died in 2002. Is that correct?
00:08:39.400 Correct. And then the story about Andrew, who obviously was about 60, 70 years too young to
00:08:46.480 die from anything, let alone a GBM, which is a tumor I've certainly spoken about on this podcast
00:08:52.620 before, and I think we'll talk a little bit more about it. Also, the other things we're going to
00:08:56.580 talk about, which are the sort of the structural failings of the system that you felt were, if I
00:09:01.280 were going to sort of try to describe your book, a big part of it is the return on investment has been
00:09:07.480 very poor. That's sort of one way to summarize it. There are many ways to sort of summarize it,
00:09:12.440 but an overarching theme has been, it hasn't been that we haven't spent a lot of money.
00:09:17.140 It hasn't been that we haven't made some progress. It hasn't been for a lack of trying, but by any
00:09:24.260 objective metric that we would apply to any standard of anything else, the return on that investment has
00:09:32.280 been so paltry that if we are not smart enough to at least consider doing something totally different,
00:09:39.560 we're completely diluted. And again, I think that's one tiny piece of it. And that's probably
00:09:44.440 that burning piece that I think your agent was ultimately saying, this is either going to erode
00:09:49.440 a hole through your, the gastric lining of your stomach, or you better put it on paper.
00:09:54.240 Yes, I agree.
00:09:55.280 So let's start with oncology. What drove you to oncology? Why did you choose to become an
00:10:01.440 oncologist in an era when women could have chosen far less demanding fields in medicine? Not that
00:10:09.080 any field in medicine is more or less demanding, but oncology is about as demanding as it gets.
00:10:14.300 What was the thinking for you? That's an astute observation actually, because
00:10:19.020 when I was going into oncology, it was the least popular field. In fact, most people, when I said
00:10:27.700 I'm going into oncology thought, okay, she couldn't get into any other fellowship. That's why, because
00:10:32.380 only Indians and Pakistanis go into oncology. Who else would in their right minds would want to go?
00:10:38.280 Except for me, it was a deliberate choice. So Peter, I was born and raised in Pakistan.
00:10:43.640 But since I was a little girl, since as far back as four years old, that is my first memory,
00:10:50.720 I was very interested in the natural world around me. I would be at four years, I'd be following ants
00:10:56.260 around and imagining all kinds of things and started reading about science for as far back as I remember
00:11:04.180 really. And as I was growing up, I got more and more interested in different fields. Embryology at one
00:11:09.900 point became an obsession. By the time I was 16, I had read all about evolution and evolutionary biology.
00:11:17.040 I had become a big Darwinian fan. Everything I was looking at was through the prism of evolution for
00:11:23.880 a long time. But then had I grown up in a country where choices were available to me, I'm confident that
00:11:31.560 I would have gone into molecular biology as a pure science or some of the one to study one of the
00:11:38.820 natural things like marine biology, maybe or probably myrmecology. And but in Pakistan, where I grew up,
00:11:47.480 there was no possibility of entering science except through medicine. So very cleverly, I thought I'm
00:11:54.740 going to go join medical school, as soon as I complete, I will proceed to the West. And there I
00:12:01.640 will start my PhD and real scientific training. But the problem that happened with me was in third year
00:12:07.760 of medical school, when I saw my first patient, one look was all it took. And I realized from that moment
00:12:15.820 on that all of my life would be devoted to somehow use the best that science has to offer to reduce
00:12:25.540 human suffering. And I have stuck to that. The second thing that happened was so I knew that I will do
00:12:33.320 research in science, but it would be therapy driven and the patient would be front and center for me
00:12:38.820 always. Second thing that happened was that I was in Karachi, Pakistan. Karachi is the largest city in
00:12:46.320 the country. And people who get sick around Karachi in the suburban areas have no access really to
00:12:54.560 medical care. It's a very impoverished third world country with a very overcrowded city where I grew up.
00:13:00.960 So cancer patients, when they came, Peter, they would travel long distances on their donkey carts and
00:13:08.000 on foot. By the time they came, they would have hugely advanced tumors that I've never seen since.
00:13:16.280 Even in Pakistan, we don't see them now. But back then in the early 70s, the kind of end stage
00:13:22.940 malignancies sprouting through breasts or like huge lumps just breaking out of people's heads and
00:13:30.240 arms and sarcomas that I saw. So it was the malevolence of the tumor, the violence of the
00:13:37.940 disease on the one hand, on the other hand, the intellectual challenge of trying to figure out
00:13:43.580 how this whole thing began in a single cell and how that cell goes rogue. What journeys has it
00:13:51.260 undertaken to reach this level of malignancy? So it was the dual emotional as well as intellectual
00:14:00.500 grip that basically caught me and at a young age. And I'm confident that if I'm given 70 more lives,
00:14:09.780 I will do exactly the same thing 70 more times. Do you still remember that first patient you saw
00:14:17.500 as a third year medical student? Do you remember what anything about them, what condition they had,
00:14:22.440 anything about them, the way they looked? Actually, thank you for asking. Absolutely.
00:14:27.560 The patient was a young woman with acute myeloid leukemia. And she was very strange because she
00:14:35.280 presented with a very large spleen as well. So we knew that she must have had a prior myeloproliferative,
00:14:41.840 myelodysplastic, some sort of a precursor that led up to the acute leukemia. So right there and then
00:14:49.340 I started having discussions with my teachers that how much easier it would be to study liquid tumor
00:14:57.200 because cells are already in suspension. And you can go in and sample them so many times instead of
00:15:02.720 trying to study a solid tumor, which is a mass that you can only remove once. Next time it appears,
00:15:09.660 it wouldn't even be the same tumor. And you don't have the luxury of accessing the tumor before,
00:15:15.840 during and after treatment. So that patient is etched on my brain as if it was yesterday's breakfast.
00:15:22.320 Yeah. I find that phenomenon to be interesting amongst many physicians, both oncologists and
00:15:28.820 not oncologists. Steve Rosenberg, who is my mentor, talks often about a patient that changed the course
00:15:35.820 of his life when he was early in his residency. A patient that had metastatic gastric cancer to the
00:15:42.040 liver five years earlier, was basically sent home to die, shows up in the ER to have his gallbladder taken
00:15:47.900 out, should have been dead five years less, six months earlier. He's completely free of tumor,
00:15:53.960 which ultimately after double, triple, quadruple checking led Steve to conclude the only way this
00:15:59.180 is possible, this is back in 1968, is if his immune system eradicated that cancer. And Steve became one
00:16:06.000 of the people who has pursued that to incredible ends. And though I've done nothing special, I still
00:16:11.840 remember the first patient I saw in the hospital. And so though it wouldn't become the catalyst for
00:16:17.060 anything particularly unique, we send first-year medical students on day one into clinic. They
00:16:23.640 can't do anything. They are literally there to just watch and try not to get in the way. But I selected
00:16:29.660 oncology and I went to the medical oncology clinic and I remember that very first patient on that very
00:16:34.780 first day. And I still remember strange details like what the color was of the clothing of different
00:16:41.380 people in the room that day. He had stage four colorectal cancer. That was probably one of the
00:16:48.060 first times I'd ever seen a CT scan and certainly seen it with such a clinical emphasis on, okay,
00:16:53.540 look, these are now tumors that have spread to both sides of his liver. The primary tumor was here. You
00:16:59.120 can see all of these places. I would go on to become very close friends with that patient who ultimately
00:17:03.960 died two years later. His widow would come to my medical school graduation two years after that.
00:17:10.480 So yeah, there is something really special about medical education and it can totally
00:17:15.240 derail the best laid plans of becoming the world's expert on ants.
00:17:21.380 Yes. And by the way, I do teach a course that is Foundation of Clinical Medicine where
00:17:27.020 first-year medical students at Columbia University are exposed to being in clinic. And I'm mindful of this
00:17:33.400 experience. How is this going to change the rest of their lives? The experience has to be
00:17:39.560 somehow we can't take away the pain. It's like Emily Dickinson said, tell all the truth, but tell it slant.
00:17:49.740 Success in circuit lies. Too bright for our infirm delight, the truth's superb surprise.
00:17:57.740 As lightning to the children eased with explanation kind, the truth must dazzle gradually or every man
00:18:09.060 be blind. So I'm very mindful of that when first-year students come to me.
00:18:16.220 Azra, you're the only person who's going to not just quote Emily in the midst of discussion,
00:18:23.600 but do so eloquently. And to think that there was any doubt you were a writer is only comical to me,
00:18:30.640 but we'll come back to that. So when you finished medical school, not only did you realize you wanted
00:18:35.680 to be a clinician, but I think the hook of oncology was already well into you.
00:18:40.240 Yes, absolutely. Now let's pivot for a moment to allow you to explain to the listener what the
00:18:49.440 state of oncology looked like at that time, specifically when you consider what it meant
00:18:57.560 to have metastatic cancer. And let's for a moment posit that we're going to talk about solid organ
00:19:03.380 tumors separately from liquid tumors. If a woman had breast cancer and either at presentation or later,
00:19:12.080 it had spread to her lungs, to her brain, to her bones. If a man had prostate cancer that had spread
00:19:18.100 to his bones, if a person had colon cancer that had spread to their liver, what was the prognosis and
00:19:24.060 how long would they be expected to survive? I think to start with, Peter, the important thing is that
00:19:31.060 when I started in oncology, it was almost a stigma to have cancer. The kind of causes of cancer we were
00:19:40.560 taught were basically either there's a genetic or hereditary component where you have a predisposition
00:19:46.340 for high risk of some sorts of cancers, or is it some environmental exposure, some kind of toxins
00:19:53.660 that you've been facing that you've been facing, or pathogens. Pathogens were considered a very exciting
00:20:00.520 new avenue for research at the time, that maybe it's a viral disease of some sort, especially
00:20:08.060 retroviruses. And clearly, there was already a very strong component of association with things like
00:20:16.480 smoking. So while there were these kinds of causative factors for cancer, most people who presented
00:20:25.360 already had rather advanced diseases, and very little screening measures were being performed at the
00:20:33.820 time. So they would come with, in Pakistan especially, with the kind of textbook pictures of
00:20:42.700 fungating masses coming, breaking through breasts in women, or men suddenly showing up within with
00:20:51.640 complete urinary blockage, unable to urinate, and we would have to do emergency kinds of things.
00:20:59.720 It was just, it would be quite devastating. And of course, there were people who, women who felt a lump and
00:21:07.020 came in. And so I remember how many times I was assisting in mastectomies and considered for a long time to go
00:21:14.420 into surgical oncology, because that seemed to be the cleanest treatment at the time. Cut it out, you don't
00:21:21.980 have to start chasing the last cancer cell with these poisonous things we were giving. Even radiation was
00:21:29.340 quite primitive at the time and quite terrible to patients. So it was all in all, it was a stigma to
00:21:36.860 begin with. People didn't want to talk about it. Many people hid it. The tumors from themselves even
00:21:42.860 would delude themselves into thinking that this is some kind of an infection, it will go away. So most
00:21:48.860 people presented with advanced cancers. The problem that I see though, before I end this answer, is that
00:21:56.940 today, in 2020, if you want to measure the success of treatment in cancer, then the thing you need to
00:22:07.080 look at, Peter, is what is the age-adjusted mortality of cancer today? In 2020, you know what it is? It is
00:22:17.260 the same as it was in 1930. So that's interesting. I usually make the statement, it's the same as 1970.
00:22:24.660 I didn't realize it was still the same as now. You go back even further. I usually just make the point
00:22:30.920 that in 50 years, it hasn't changed. You're saying in 90 years, it hasn't changed.
00:22:36.380 Yes. I'm saying that because the 30% or 27% decline in mortality we are seeing in the last 30 years
00:22:44.800 is following a 30 years increase in mortality in cancer. You see, what happened was that with all
00:22:52.360 the smoking, anyone who watches Mad Men is shocked to see it, like my daughter saw it and she was,
00:22:58.380 mommy, is that what people used to be? Like everywhere, they were just smoking. Everybody
00:23:03.460 was smoking. This led to such an increase in the incidence of cancer, so that the decline in mortality
00:23:12.520 basically parallels the decline in smoking. That is all that has happened. Otherwise,
00:23:18.560 we are really at square one. And that is the embarrassment that nobody wants to recognize.
00:23:27.040 In fact, somebody asked me the other day, what exactly is your point in saying, I said, look,
00:23:33.040 Nietzsche's Thus Spake Zarathustra opens with this man running around with a lamp at noon in the middle
00:23:40.900 of the market saying, I'm looking for God. For me, it's like I'm running around looking for an adult
00:23:47.360 in the room.
00:23:48.820 Yeah. So let's explain to people, let's explain some of the nuance here because most people are
00:23:54.580 confused by what an extension in disease-free survival means. Not that the average person knows
00:24:01.980 what the difference is between a PR and a CR, but you and I both know this world well because we've been
00:24:07.460 on the inside of how these clinical trials are run. So we understand that, hey, this drug got
00:24:13.240 approved because X number of people met the criteria for a PR, which has a kind of a funky arbitrary
00:24:19.920 definition, if you're going to be brutally honest, of what a partial response is defined as. A complete
00:24:25.260 response is a little easier to define. But then we don't talk about what durability means in all of
00:24:30.240 these things. So I could give an entire soliloquy and lecture on this, but I'd much rather listen to
00:24:35.640 you do it eloquently because the chance that you're going to quote more poetry is reasonably high.
00:24:40.260 So can you explain for folks what it means to have a partial response, a complete response?
00:24:46.800 And the reason I think it's important to do this, even though it sounds a little dry,
00:24:51.540 you're saying things that seem completely at odds with what the propaganda machine is saying.
00:24:57.420 Now, I know you're right because I know how the sausage is made. I've been inside the belly of the
00:25:04.160 sausage. I understand how to read the literature. That is actually asking a lot for someone who
00:25:10.840 maybe just wants to better understand oncology, but they haven't had the luxury of training in
00:25:16.180 oncology or even more importantly, I think doing research in oncology. So can you go through some
00:25:22.120 of the fundamentals of what these semantics are that are used, how these terms get thrown around
00:25:27.480 and how ultimately it can lead to some statements like the one you just made, frankly, which is as
00:25:33.840 extreme as extreme could be with respect to saying, hey, look, in 90 years, we really haven't gotten
00:25:40.660 better at extending life in people with cancer once they have cancer. So let's unpack some of these
00:25:47.320 definitions a bit. I think that's a good place to start. So let me begin by a little bit of just
00:25:54.700 history, because before we get into nuances, why not just talk about the very gross facts?
00:26:01.700 Cancer is a very bad disease. Everybody knows it. The only good news you can give to a cancer patient
00:26:07.500 is that, oh, we caught it early so we can get rid of it. So we know that cancer itself may not kill.
00:26:14.960 It's the delay in treatment that really kills. So the earlier we pick it up, the better. How have we
00:26:21.120 treated cancer which has been found even in mummies? So we know cancer has existed all along. But the
00:26:28.280 incidence, probably it is a disease of modernity associated with many, many of our lifestyle
00:26:34.760 changes from hunter-gatherer society to modern human. Nonetheless, cancer was identified in mummies
00:26:42.740 and has been there all along in human history. How have we treated it? Well, the first treatment of
00:26:50.200 cancer, even though it wasn't even called cancer then, was in 500 BC when the Persian queen Atossa
00:26:57.160 had felt a lump in her breast. She tried to hide it by covering it with sheets and things and eventually
00:27:04.580 asked her Greek slave who took out his sword and simply slashed off her breast. She survived it.
00:27:11.640 She was the wife of Darius and she survives it. And this is the first known surgery. We were slashing
00:27:20.760 women's breasts in 500 BC. What is the primary treatment for breast cancer today? Same slashing.
00:27:29.280 And we typically give Halstead credit for that.
00:27:31.600 So this is my point that for 2,500 years, what has exactly changed? Slight better scallopels and
00:27:39.620 giving anesthesia while doing it? Okay, yes. Then second is that when you couldn't, so whatever
00:27:47.220 cancer was detected early enough as a solid tumor was cut out and the liquid tumors you couldn't cut
00:27:54.260 out. So you needed to poison them somehow. Now, how do you poison these things? There was really
00:28:00.800 nothing could be done about it until in the First World War. Of course, it wasn't called the First
00:28:07.320 World War because we didn't know there's going to be a second. So it was called the Great War.
00:28:12.620 Part of development of weapons against each other was use of chemicals. And so when these vats of
00:28:19.280 chemicals were sitting around that were dropped on humanity, people noted that one of the side effects
00:28:26.740 that people died from was low blood counts. So Goodman and Gilman, two pharmacologists sitting
00:28:34.220 around in Yale, decided that this could be used to treat cancer then, these chemicals. So do you know
00:28:40.880 the first three chemical weapons that were used to treat cancer? Cytoxan, Chlorambucil, and Melphalan.
00:28:48.260 We still use at least two of those.
00:28:50.420 I gave all three with my own hands to my own husband, Harvey. So we are slashing, we are poisoning
00:28:58.720 the same way, and then burning with radiation therapy the same way. So I wanted the audience
00:29:06.040 to understand the kind of dramatic statements or melodramatic statements that I'm making are
00:29:14.160 not baseless. People just have to stop deluding themselves, open their eyes and see what is in
00:29:22.320 front of them. So to just finish this part with a quotation of statistics. In this day and age today,
00:29:32.220 68% of cancers that we diagnose, new cases, 68% are cured. Cured with what, Peter? Slash poison burn,
00:29:43.440 surgery, surgery, radiation, and chemo. Except for a few cancers where there are targeted therapies or
00:29:52.400 antibodies available, really not much has happened. The 32% who present with advanced disease that we
00:30:02.400 can't use slash poison burn. So imagine the same treatments that were working in earlier stages
00:30:08.720 are not working in later stages. This is the best proof that the only thing we can do right now is
00:30:15.620 to find the cancer earlier. And even some of the therapies not working, like targeted therapies,
00:30:21.740 may work better if we don't give them to stage 4. FLT3 mutations caught early may respond much better to
00:30:29.940 FLT3 inhibitors. This is the point I will keep making over and over.
00:30:35.900 I want to stop you for a second there, Ezra, because honestly, that is something that I have
00:30:43.040 only in the last few years come to share your zeal for, and I can't emphasize it enough. So there was
00:30:50.900 a day when I believed, incorrectly now, I believe that I was incorrect, that burden of tumor was not
00:30:58.580 the primary determinant factor. Stage 4 cancer was stage 4 cancer, whether the burden was high or low.
00:31:04.580 And it was really a property of the biology of the cancer that was the issue. So in other words,
00:31:09.800 if you took a whole bunch of women with stage 1 breast cancer, you took 100 women that had sub
00:31:16.400 centimeter lymph node negative breast cancer, and you had a machine that could tell you which ones
00:31:24.100 had the potential to go on to have metastatic cancer versus those ones that did not. And let's,
00:31:30.400 maybe breast cancer wasn't a great example because of the hormone complexity of it.
00:31:34.580 That whether you acted then or acted later, it wasn't going to matter. Well, I no longer believe
00:31:40.460 that is true for reasons I could expand upon. I want to emphasize the point you're making,
00:31:46.000 which is, I mean, it's the contrapositive of your point, which is, we don't really have therapy that
00:31:51.620 works for systemic disease. So metastatic breast cancer, metastatic colon cancer, metastatic prostate
00:31:58.600 cancer, metastatic, you fill in the blank, you are no better off today than you were 50 years ago.
00:32:06.300 And that is a very sobering, if not outright depressing statistic. It's very difficult for the
00:32:15.400 average person to comprehend that for all our advances, once colon cancer has gone to your liver
00:32:22.140 in 2020, you are almost as hopeless as you were in 1970. And in fact, you can probably put more color
00:32:29.660 around it and say, well, technically, Peter, you might live four and a half more months. And I don't
00:32:34.600 want to discount that. I want to talk about what the cost of that is. But I mean, do you agree with,
00:32:39.160 am I also being a little too dramatic? Or would you agree with my assessment?
00:32:43.320 I think you're using meiosis, meaning understated.
00:32:49.000 Seriously, how do you tell a 22 year old, Andrew, that we will add four months to your life,
00:32:56.100 you should go and celebrate and proclaim from the rooftops? What kind of nonsense is this?
00:33:01.820 Four months of improvement in survival. And that is the lucky ones who get it. You know what it is,
00:33:08.000 why people will be shocked. Why should they be shocked? They'll be shocked because they are
00:33:13.100 listening. Poor things have been subjected to the ultra hype of all this self-promotion of scientists
00:33:20.820 and oncologists patting themselves on the back for game changers that they have. Allow me to expand on
00:33:28.900 what has, in my opinion, put the field back by decades. And that is the treatments that are
00:33:37.320 most celebrated in cancer are treatment of chronic myeloid leukemia. This is a disease which is a
00:33:46.680 disease of the myeloid cells in the bone marrow, which undergoes a chronic phase where nothing much
00:33:53.020 is happening, except one fine day, something mutates, something happens, the disease takes off
00:33:58.480 into an accelerated phase and then becomes acute leukemia. And it is universally fatal.
00:34:04.000 And all of us who are older, like me, have taken care of dozens of these patients who died in our
00:34:10.960 own hands, young people, as well as old. Well, it turned out that chronic myeloid leukemia is caused by
00:34:19.760 one genetic change that can be targeted with one magic bullet. And that magic bullet is Gleevec.
00:34:26.700 And that was FDA approved in 2000. And now these people are being cured with one drug. And this is
00:34:33.660 a fantastic success. But Peter, the same drug doesn't work when the disease starts to accelerate.
00:34:41.460 So chronic myeloid leukemia, think of the word chronic here. It's not really a malignancy. It's like a
00:34:49.340 pre-leukemia right now. You caught it early. At that stage, there was only one problem and you
00:34:57.440 could fix it with one bullet, right? Can we put that in perspective for people? Because I want to
00:35:02.720 make sure we're not, I don't want the naysayer to have too much wiggle room to say, well, you've
00:35:08.260 discounted the success stories, Gleevec. We're going to probably talk about some of the checkpoint
00:35:13.980 inhibitors as well, which have probably been the single biggest victory in the past five years.
00:35:19.180 Do we have a sense of what percentage cancer mortality has come down on the back of Gleevec,
00:35:25.300 not just from CML, but let's also look at GI stromal tumors, which have at least for some period
00:35:30.900 of time responded to Gleevec, though it might not be the most durable remission ever. I mean,
00:35:36.000 what type of numbers are we talking about? Has that put a 1% dent in cancer mortality in the past 20 years?
00:35:41.860 If that. It's a very rare disease.
00:35:44.660 Yeah, yeah, exactly.
00:35:46.040 Very rare, but it did prove a point, which is that targeted therapy can work.
00:35:52.420 This is the point I'm making, that it's not even really a cancer yet in all its malignant
00:35:57.700 manifestations that other cancers are. The second thing we celebrate is again in hematologic
00:36:04.540 malignancies, which is acute promyelocytic leukemia, which is cured with arsenic or with vitamin
00:36:11.740 A analog, vitamin A, let's say ATRA. It cures acute promyelocytic leukemia, one of the deadliest
00:36:19.000 acute leukemia. But do you know, it wasn't as if scientists sat down, studied this disease,
00:36:25.360 found the lesion of retinoic acid receptor and started to reverse it. Poor Chinese were saying
00:36:31.420 for years that we are curing acute promyelocytic leukemia with vitamins and the West didn't believe
00:36:38.740 them. And finally, they sent somebody over and they saw all the patients and were convinced and
00:36:46.040 came back and did a trial of ATRA here and then were convinced and then worked backwards to find
00:36:52.600 the molecular lesion. So please, scientists do not take credit in front of me for acute
00:36:59.500 promyelocytic leukemia. You did not work it out. You only worked it out in retrospect.
00:37:04.320 So those are the two biggest advances. Now, lymphomas absolutely agree that throwing cocktails
00:37:12.160 of chemotherapy together, testing this one and that one, they worked as because of the biology
00:37:17.820 of the disease that was responsive to those chemotherapies. That's what I'm telling you,
00:37:22.560 that some of the things that have retarded progress in a way is because we become convinced
00:37:28.620 of a paradigm that, oh, if Hodgkin's disease can be cured with these four drugs, we just have to find
00:37:35.400 the right four drugs for pancreatic cancer or ovarian cancer and we'll fix it. And that's how we kept
00:37:41.360 working, throwing crazy combinations of drugs together to follow the paradigms. The few successes
00:37:49.060 that we had seen, Hodgkin's disease, a few non-Hodgkin's lymphomas or acute promyelocytic
00:37:55.960 leukemia, chronic myeloid leukemia, I mean, my multiple myeloma now has been very successfully
00:38:02.600 treated, but at that time it wasn't. But now it is definitely a night and day difference.
00:38:10.020 But these are again, rare types of cancers, melanoma, dramatic differences in survival today.
00:38:17.960 But again, all of these together would account for less than 10% of cancers together. Still,
00:38:26.120 we have to go back to whatever we can slash poison and burn. And successfully, we are able to do that
00:38:33.500 for 68% cancers, either because their disease is responsive, like in Hodgkin's lymphoma, even if
00:38:40.100 it's advanced or non-Hodgkin's lymphoma or CLL, or because it is amenable to surgery. That's it.
00:38:49.300 So where a counter argument here is, look, this is going to be a game of inches. And the 10%
00:38:57.440 that you just described, you basically gave the tour de force explanation of oncology's greatest hits
00:39:03.540 in the last three decades. And again, we didn't pay a lot of, spend a lot of time on it, but I think
00:39:08.960 the checkpoint inhibitors also have this huge impact beyond just melanoma, because anybody who
00:39:14.420 shows up with a checkpoint mutation, even if you have Lynch syndrome and you go on to get pancreatic
00:39:20.080 adenocarcinoma, you're probably going to respond. Let's just say that adds up to eight or 9% of the 68%.
00:39:26.860 So the skeptic would say, but look, Azra, like that's amazing progress. Give us another 40 years,
00:39:34.640 give us another 30 years, and cancer is eradicated. That would be the optimistic view of this.
00:39:41.480 How would you counter that view? I don't want to counter anything. I mean,
00:39:47.500 that's the way the field has been. I've been hearing the same self-satisfied voices saying the same thing,
00:39:54.380 how wonderful they are, how they will understand every intracellular signaling pathway in the cancer cell
00:40:02.100 and reverse it, how they will understand the metabolism. Don't even get me started on that,
00:40:07.360 because it's as if the last hundred years haven't existed, and people haven't had any ideas until these
00:40:14.080 new investigators came around to, on their white horses, with their overconfidence and contempt for
00:40:20.460 the past, armed with new things. We are going to reverse all these. I mean, clearly, whatever advances
00:40:28.800 there are, and I don't want to argue with anyone about advances, you are saying there are a lot of
00:40:34.480 advances, great. Do they really reflect the quarter of a trillion dollars we have invested in research?
00:40:42.620 Is this all we have to show? A few checkpoint inhibitors? Fine, I agree with you, even if I agree with you.
00:40:48.580 So, let's just talk about immune therapy for a minute. You say checkpoint inhibitors. There are
00:40:54.600 many different kinds of immune therapies, 14, 15 different kinds. The two most popular we talk
00:41:00.980 about when we talk about immune therapy these days is either the cell therapies that are given,
00:41:08.120 where you train the lab that is the pioneer of all of this, work with cell and cytokine,
00:41:14.720 IL therapies combined with T cells, etc., or the checkpoint inhibitors, because normal cells will
00:41:22.560 have signals on themselves saying, eat me or don't eat me, and these can be masked, and these signals
00:41:28.220 are the checkpoints. And by using drugs, you can unmask the signal, which has been covered up by the
00:41:36.740 cancer cell. Very simple explanation for checkpoint. So, the two main ideas in immunology that came along
00:41:44.000 were how to target these checkpoints so that the body's own immune cells can recognize the cancer as
00:41:52.140 being alien to the normal functioning of the body and must be eliminated. And the second is,
00:42:00.000 can you take the body's own immune cells and engineer them in such a way that they can selectively kill
00:42:09.600 cancer? And CAR T cells have been proclaimed once again as revolutionary. Of course, the science behind
00:42:19.660 it is beautiful. It's very sophisticated. It really, it's one of those things that make you want to
00:42:27.920 celebrate humanity's accomplishments. It is just a gorgeous thing. But the problem is that it has done
00:42:35.240 very little for patients. Why? Because what all the oncologists talking about CAR T never mention in
00:42:44.260 any of their talks. And by the way, every morning, I run every morning. And after I run, I jump on a
00:42:51.800 small trampoline for 20 to 30 minutes every day. Because that's one way to stimulate your lymphatic
00:42:58.460 system. And the trampoline is small rebounder, I should say, not a trampoline. It's one of the best
00:43:04.220 exercises you can. I've been doing it for 25 plus years. So during that time, I listened to YouTube
00:43:11.380 lectures. To all of you cancer researchers out there, understand that there is one person who
00:43:18.080 listens to your YouTube lectures every single day. And the kinds of things people confess to in public
00:43:25.440 forums, very different than the scientific papers they're writing. In all of those talks, I have never
00:43:32.900 heard any serious scientist, oncologist or immunologists say that their CAR T cells cannot
00:43:41.980 distinguish between normal and cancer cells. They just ignore that. It's like they just don't want to
00:43:49.780 acknowledge it. Why don't you say that basically CAR T cells are just another form of killing machine
00:43:57.760 indiscriminately. So what CAR T cells do is whatever antigen you put on it, and whatever organ expresses
00:44:05.700 that antigen, it will go destroy the whole organ, taking down every normal cell of that organ also.
00:44:14.380 So basically, the only thing CAR T is working for right now is B cells, because you can replace B cell
00:44:20.900 function. After you kill every single last B cell in the body, but you can't do that to pancreatic
00:44:27.300 cancer, because it will kill the whole pancreas. And then you can't replace the function. But how many
00:44:33.460 times have you heard people say this, Peter? Well, I mean, do you hold out hope that some of the case
00:44:40.140 studies, because we've seen the case studies, the cholangiocarcinoma here, the pancreatic cancer there,
00:44:44.960 the colon cancer, the breast cancer there, where they are able to identify the unique antigen
00:44:50.420 of the cancer. And by unique, I mean distinguishing antigen of the cancer, such that you can send the
00:44:56.760 T cell loose, and it can eradicate not the entire biliary system, but just the cancerous piece.
00:45:03.620 And to be clear, I'm not speaking one way or the other, other than to sort of help me think through
00:45:09.820 the, is this a sufficient proof of principle that we believe that adaptive cell therapy,
00:45:17.280 of which CARs are the most far and away the most prominent, and checkpoint inhibitors are really
00:45:22.440 going to be the way of the future. You didn't allude to it. You and I know this as well as Tuesday
00:45:26.580 follows Monday. There are also very nasty side effects of checkpoint inhibitors. And for every
00:45:32.080 patient we see who has a response to them, some of the autoimmunity can be quite devastating.
00:45:37.240 And in fact, vitiligo for a patient with melanoma might not be such a fatal form of autoimmunity,
00:45:43.500 but certainly when people have life-threatening enterocolitis, yes, they're cancer-free, but they
00:45:50.040 die from bowel disease that follows. So certainly not to suggest these are benign. I guess the point is,
00:45:55.880 do they represent a demonstrable step function forward that now puts us in a new era of, okay,
00:46:03.500 we've found a new beast that goes beyond surgery, radiation, and indiscriminately killing chemicals.
00:46:10.980 How do we figure out how to tame this new beast? Does that resonate?
00:46:15.480 No, not particularly because Steve Rosenberg has found this ages ago that this is the right way to
00:46:21.260 go. But yes, we are making advances. And I do think that all of these need to continue. I'm not saying we
00:46:28.620 should stop any of this. I'm just pointing out where the field is right now. I think these are
00:46:33.740 fantastic. They should continue what needs to stop. Here's the problem. 95% of experimental agents that
00:46:42.980 we bring to the bedside today, 95% in cancer fail completely. The 5% that succeed should have failed
00:46:52.680 because they are only prolonging survival for 20 to 30% of patients by a few months. And you began by
00:47:04.900 asking me, what is progression-free survival? I mean, we don't even talk about survival anymore.
00:47:12.000 We just talk about progression-free survival because survival has become too big of an obstacle
00:47:19.100 to overcome. So as long as you don't see the tumor, but the patient dies within the same four months or
00:47:25.680 five months, it doesn't matter. But you didn't see the tumor for two and a half months, that's
00:47:30.260 progression-free survival. So this drug should be approved and the sponsors of the drug will make
00:47:35.920 billions of dollars. Let's stop on that because it is just so darn important. Let's use a tangible
00:47:43.080 example. Avastin. Okay. I don't want to put you on the spot because I don't remember the numbers of
00:47:49.460 Avastin, but the only reason I bring it up, is that an okay? Do you know enough of the examples that I
00:47:53.100 could use Avastin? I mean, I don't use it myself, but I do know that it's one of the more successful
00:47:59.380 We could pick another one that you know. I'll explain. So Avastin was a blockbuster in the sense
00:48:04.560 that it was the first of its kind and it explored a brand new idea. So Judah Folkman had this idea that
00:48:10.680 many others followed in the footsteps of, which is, look, if a tumor can't make new blood vessels,
00:48:16.440 it can't get very big. Therefore, the ability to make new blood vessels must be of paramount
00:48:22.600 importance to metastases. And therefore this concept of neovascularization became key.
00:48:30.000 And so this was a beautiful story of science and pursuing this thesis and doing all of these
00:48:35.100 experiments. And one step leads to another. And before you know it, you have a whole class of drugs
00:48:39.700 called anti-VEGF drugs, of which this drug, and I assume it was Genentech's drug. I can't even
00:48:46.740 remember at this point, but I think it was Genentech that was the first in line. They have this drug,
00:48:51.880 Avastin, and I believe colorectal cancer was one of the first places they looked. Again,
00:48:57.900 in the show notes, we'll have the story more accurately laid out. But the gist of what I remember,
00:49:03.460 Azra, is the following. You took a patient that had metastatic colorectal cancer, which again,
00:49:09.700 means this is a patient who had a colon cancer that has left the colon, left the lymph nodes. It is
00:49:15.680 now somewhere else, usually in the liver. This is a patient who is absolutely not going to live.
00:49:22.500 And if 1% of those people live five years, that would be very generous. And this is asking the
00:49:27.840 question, if you use all of the standard therapies we have today, the entire cocktail of chemotherapies,
00:49:34.500 and then you do the same thing, but you also use Avastin, how much do you change the median
00:49:41.060 survival? Notice we don't use mean, because that can be very impacted by outliers. We use median.
00:49:48.760 And I believe the answer with Avastin was on the order of four months. With Avastin, which cost at the
00:49:55.580 time in the neighborhood of $100,000, it was going to extend median survival for those patients by four
00:50:03.200 months. And what I remember most about the discussion, Ezra, is it prompted a discussion
00:50:09.800 about what is the value of a life. And different countries around the world, especially countries
00:50:16.260 without private insurance, but instead those with public insurance, had to put something called a
00:50:21.880 quali at the front of that discussion, a quality adjusted life year, which says, do we believe
00:50:28.800 that the cost of a life is worth X hundred thousand dollars such that a publicly funded
00:50:35.700 insurance for health would be accountable to spend that money? And if you don't like that example,
00:50:41.160 because I might not have the details right, that you can use a thought experiment, which is if I told
00:50:46.600 you, Ezra, you have a condition that is going to allow you to die, but I could extend your life by a
00:50:52.280 month and it's going to cost a billion dollars. Do we as a society think that that's a reasonable cost
00:50:59.060 for society to bear on your account, despite how wonderful you are and how much amazing stuff you
00:51:05.000 could do with an extra month? So it started to get into this discussion of the cost benefit analysis,
00:51:11.940 which gets to that return on investment. Do you want to use a better example, a more recent example
00:51:16.880 than Avastin, to illustrate how relatively small changes in median survival or disease-free
00:51:25.760 progression? And maybe you can explain the difference between those two, because you and I will go back
00:51:30.120 and forth between them, but I think the listener could be confused. And then again, just talk about
00:51:34.500 the literal economics of that, because I do think people will be staggered by what the actual numbers
00:51:41.560 are. You know, John Donne said something very beautiful. So when you said give a literal example,
00:51:48.580 I'm going to give a literary example. No man is an island entire of itself, each a part of a piece of
00:52:00.520 the continent, part of the main. Any man's death diminishes me. That's what you said. What is a human life
00:52:09.520 worth? John Donne says, any man's death diminishes me because I am for mankind and therefore never
00:52:20.300 sent to know for whom the bell tolls. It tolls for thee. Of course, every human life is important. And
00:52:28.520 of course, every oncologist is working to try and save every human life. I'm not saying we are deliberately
00:52:36.000 not doing enough. In fact, in all of my career in this country, in the last 43 years, I have yet to
00:52:43.640 meet an oncologist who didn't care for their patients. Never. They're all trying their hardest.
00:52:50.740 But it's like trying to use a map to find your way in London, but you're using a map of Paris.
00:52:57.980 It's not going to work. So how have we become so misdirected? You asked me to give a more recent
00:53:07.060 example or something I'm familiar with. I started, landed in this country in 1977 as a fresh medical
00:53:15.000 graduate. Before my residency could start, I had six months and I'm not someone who can sit around at
00:53:22.680 home doing nothing. So I asked my sister, my older sister who had just finished a rotation. She was
00:53:31.220 a pediatric resident in Buffalo, New York. I was staying with her and she just finished a rotation
00:53:37.360 at Roswell Park Cancer Institute. And I said to her that, you know, all the oncologists there,
00:53:44.100 can you get me in there and I'll just work for six months that I have. So she went and spoke to her
00:53:50.240 boss, Arnie Freeman. And he said, well, if she's half as good as you, we'll take her. So I joined
00:53:56.780 pediatric oncology at Roswell Park. But within a couple of months, it was very clear I couldn't handle
00:54:02.860 it. I couldn't last because I was crying the whole time. I just can't handle children being sick.
00:54:09.440 So my sister's friend, who happened to be my boss at the time, Judy Oakes, one day just took me by
00:54:15.740 hand because I was hiding in a room crying away. I had lost a four-year-old that day and took me to
00:54:21.660 the adult oncology unit where I met Harvey Prysler, who was later to become my husband. And Harvey was
00:54:29.600 heading the leukemia program at the time at Roswell Park. And he took me on. I started working on the
00:54:36.920 wards immediately. At that time, we used to have 20, 30 AML patients, acute myeloid leukemia patients
00:54:45.540 on the floor. And I started seeing and working completely as a fellow. I was hired as a fellow.
00:54:52.200 We were using two drugs to treat AML back then in 1977, a combination of aracy and donomycin.
00:55:01.840 They were popularly known as seven and three because you give seven days of one and three
00:55:07.820 days of another. By the way, Harvey and I started to use this seven and three as a kind of a code
00:55:15.000 word between us. We would be sitting in a meeting and Harvey would suddenly leave no one and say to
00:55:20.240 me, as that person is doing seven and three. And for us, that seven and three meant somebody is
00:55:25.880 using seven words when three would suffice. Another mark of a great writer.
00:55:33.100 So we were using seven and three in 1977. Guess what we are using in 2020? Seven and three.
00:55:41.440 All these years, imagine the thousands of patients I personally have had to see and describe the same
00:55:53.720 side effects and the same potential benefits they will have. Now, when I started, the survival was
00:56:03.120 10% five-year survival with seven and three. Today with the same drug, it's about 26%. Why has it
00:56:10.200 increased? Because the supportive care measures are better. We have better antibiotics. We can give
00:56:17.040 more platelets and red cell transfusions are easier to give. We have learned to manage better.
00:56:23.720 That's it. The supportive care is better. But the backbone of treatment is the same seven and three.
00:56:29.660 So now a company comes up with combining these two drugs, seven and three, in a fatty envelope.
00:56:39.140 So they come up with this new drug now, and it's the same seven and three. But it gets approved in this
00:56:47.140 country. And this approved form, which is, I believe, for a little older patients, like 60 to
00:56:53.440 75 years, if you have acute myeloid leukemia, you can get this combination of seven and three,
00:57:00.120 which is inside this fatty capsule. Now, the regular seven and three costs $5,000.
00:57:07.920 $5,000 for how long?
00:57:10.100 For the seven days and three days.
00:57:11.500 For the seven plus the three days for one cycle. Okay.
00:57:14.000 $5,000. This fancy version, seven and three costs $45,000. And do you know what is the
00:57:22.980 improvement in survival? Under the best conditions when they ran the study where you select patients,
00:57:32.340 the eligibility criteria are so stringent. Their kidneys have to be working, their liver has to be
00:57:39.960 working, their lungs have to be at capacity, et cetera, et cetera. You know how we choose and
00:57:45.760 select patients for clinical trials. They are the best of the best.
00:57:50.140 Right. They have to be cherry-picked. They represent the upper limit of what you expect in the real world.
00:57:55.100 Yes. And even in those cherry-picked patients, the basis on which this $45,000 combination is approved
00:58:04.320 is an improvement in survival by 3.7 months. That is a median improvement in survival,
00:58:11.200 which means a fraction of the patients, like maybe 30%, experienced 3.7 months improvement
00:58:19.260 in survival. What does that mean? Median survival. So even out of those 30%,
00:58:24.120 half of them didn't even experience that, but we are paying $45,000. Now, if I don't prescribe
00:58:32.440 that drug and continue to give 7 in 3, then I can go to jail. Because tomorrow, if the patient dies,
00:58:41.820 which they eventually do because it's an older age group, then the family will sue me. Dr. Raza,
00:58:48.580 this drug was available. It could have given 3.7 more months. So now the decisions that we are making
00:58:54.980 as individual oncologists are not being made by us, they are made just by key opinion leaders or
00:59:02.940 the very institutions like FDA, which are supposed to protect the patients, have fallen a victim to
00:59:11.420 this kind of propaganda where under the pressure of advocacy groups who are demanding more drugs
00:59:18.920 for cancer patients at any cost. Just to be able to say that we have 72 new drugs being approved this
00:59:27.340 year for cancer. Look at the fantastic advances we have made. So under pressure from advocacy groups,
00:59:35.840 from patients, the FDA has lowered its bar of approving drugs to laughable criteria. It would be
00:59:43.960 laughable if it wasn't so tragic. Here you have 3.7 month median improvement in survival for a fraction
00:59:52.440 of the patients for $45,000 instead of $5,000. Are you surprised then that 42% of cancer patients
01:00:02.680 who are diagnosed today will be completely financially ruined by the second year of their diagnosis?
01:00:10.220 50% of breast cancer. 50% of breast cancer women are being hounded by collection agencies with stage 4
01:00:17.440 cancer. Your friend Marty McCary has written a fabulous book, The Price We Pay. People should read
01:00:24.920 that book and see the obscenity we have reached. The vulgarity of it all, completely not thinking about
01:00:34.100 patients at all. Talking in terms of, well, Azra, 3.7 months meant a lot to my patient who could go and
01:00:41.460 attend his son's graduation or grandson's bar mitzvah. Yes, of course, like I said, John Dunn said,
01:00:48.600 every human life is important. But you asked the question earlier, at what cost to the others?
01:00:55.240 I mean, I think Marty's work does a great job of explaining this. And the only way I can sort of
01:01:01.360 explain it is, I think the United States has basically become the one that has to subsidize
01:01:07.940 the rest of the world in terms of medical research. I mean, that's the only way I can sort of make sense
01:01:13.380 of how outrageous these costs are. By the way, that's not a justification. So I could go on for
01:01:19.100 days as to how frustrating it is. But it has basically become a form of subsidy. And I've been
01:01:24.860 trying to get my head around what are the biggest drivers of spending in the United States. Because
01:01:31.580 overall, as a country, we don't get a lot in exchange for what we give. That's going to be a
01:01:38.700 very polarizing comment I just made. So let me clarify it. If you take someone in the top income
01:01:44.400 tax bracket in Canada, by all estimates, a socialized country, and you compare them to someone
01:01:51.280 in the top income tax bracket in the United States, especially in a high tax state, they're paying
01:01:55.860 about the same amount. The difference, however, in what they get is fundamentally quite different.
01:02:01.220 In Canada, everybody gets health insurance, no ifs, ands, or buts. Everybody basically gets
01:02:05.980 exceptional education at a fraction of the cost, homelessness, mental health. A lot of these issues
01:02:11.680 are just so much better. I still think, I would still make the case, by the way, that the extremes of
01:02:16.860 healthcare are better in the United States. I would much rather receive my medical care in the
01:02:21.260 United States than in Canada. But ultimately, it points to a gross inefficiency in terms of how
01:02:26.440 those dollars that are collected are then turned around and spent. And I could probably point to
01:02:31.140 three things that the United States is disproportionately spending money on that other countries are not
01:02:37.180 spending money on. And it's those three things that are creating the biggest gap. And one of them
01:02:42.380 is healthcare. There's simply no way to avoid it. And within the morass of healthcare, drugs might be one of
01:02:49.780 the most egregious examples. There are others that are less sexy to point your finger at. But as you
01:02:55.780 note, I mean, Marty makes a very good point that the drug story is a revolting one, actually.
01:03:01.460 After Harvey died with a five-year-long battle with leukemia.
01:03:07.160 You are in your early 40s at this point in time, basically, when you're widowed?
01:03:11.260 When he was diagnosed, yes. And we had a four-year-old daughter when he was diagnosed. So after he died,
01:03:18.720 my younger sister, who's now the head of women's radiology at the Brigham, she said,
01:03:23.700 well, I have to get you out of Chicago because this five years of thinking of nothing, concentrating
01:03:30.740 continuously on this one thought only, which was Harvey and his illness.
01:03:37.640 So we went to England because, well, London is one of my favorite cities. And I wanted to take my
01:03:46.620 daughter to see Reading Jail because I'm a big Oscar Wilde fan. And we went to Reading. And
01:03:54.760 the reason I'm telling you this is one of the most gorgeous ballads ever written, the Ballad of Reading
01:04:01.640 Jail. The refrain is very beautiful. Yet all men kill the things they love. By each, let this be heard.
01:04:12.220 Some do it with a bitter look and some with a flattering word.
01:04:19.840 The coward does it with a kiss, the brave man with the sword. But each man kills the thing they love.
01:04:27.600 By each, let this be heard. So Wilde wrote this poem when he was in this ballad, when he was
01:04:35.880 incarcerated in jail. And when he came out, his boyfriend, Lord Alfred Douglas asked him,
01:04:42.060 what do you mean by this refrain, all men kill the things they love? What does that even mean,
01:04:47.020 all men kill the things they love? And Wilde tried to just diss him and said, well, nothing,
01:04:51.860 you know, it's just whatever. But Bosie, Alfred Douglas kept insisting, no, you have to tell me
01:04:58.440 what this means. So you know what Wilde said? He said, look, it's like this. When we meet someone
01:05:04.580 or we have an idea, we make immediately an impression in our mind. We meet them the next time
01:05:12.660 and they don't correspond with the impression we had. So instead of correcting our impression,
01:05:20.480 we start trying to change the person. And this is how we enter the cycle of self-delusion and kill
01:05:27.760 the thing that we love. Why am I telling you all this is because we started with good intentions,
01:05:36.780 Peter. But somehow, remember in the beginning, I said, I'm looking for an adult. Why?
01:05:42.660 Why aren't we taking stock of the situation? Why is it that scientists who are going to now,
01:05:50.620 let's say, attack the metabolic pathway of cancer cells to improve the efficiency of chemotherapy
01:05:59.000 by simultaneously changing the dietary patterns for the patient? A very good target to think about.
01:06:10.220 But before even a phase one trial has started, they are monetizing it, making companies out of it.
01:06:18.020 I mean, yes, this is a capitalist system. Everything is legal. Everything is allowed. But then
01:06:23.140 it somehow leaves such a bad taste in my mouth all the time. All the time. It's all about,
01:06:31.180 think about it. You are never going to be able to cure an advanced cancer of the kind that Andrew had
01:06:40.260 by a diet of any sort, or even by supplementing chemotherapy he's getting with a diet of any
01:06:46.740 sort. All you are aiming for is improving their survival by a few months. But more important is to
01:06:54.700 make companies. Why? Why have they come to this?
01:06:59.300 I mean, I think in defense of that type of idea, which I don't really know about specifically,
01:07:04.720 they would probably argue changing nutrition. If a change in nutrition could have a comparable
01:07:11.360 benefit to a change to the use of a drug, it's a fraction of the cost, and presumably without the
01:07:17.440 destruction of the quality of life. I mean, one of the things I'd like you to come back to, Azra,
01:07:21.240 is... I didn't question the idea, Peter. Sorry, I'm not questioning the idea at all.
01:07:26.620 I'm questioning why do you have to monetize everything, is what I'm questioning.
01:07:31.160 Yeah. I mean, I was going to ask you the same question, which is how do we think about the role
01:07:41.460 of pharma in this entire landscape? I mean, it can't be denied, which is progress has to be funded
01:07:49.740 by somebody. You have different animals. So you have public funding, which has been the majority of
01:07:56.160 it through NIH via NCI, which is by far the largest of the institutes within NIH, and has done the
01:08:03.320 lion's share of the cancer funding. So I actually did the analysis five years ago, which means it's
01:08:09.220 probably dated, but directionally correct. But if you went back to the declaration by Richard Nixon
01:08:15.980 of the war on cancer, so circa 71, 72, more than half of the total research dollars in the world
01:08:24.880 into oncology funneled through NCI. Slightly over half was my recollection. Again, I could be a little
01:08:31.120 wrong on that, but that's a big piece of it. Of course, pharma, as you know, has really outsourced
01:08:37.980 R&D. They just don't do R&D anymore the way they used to. So they basically now acquire R&D'd products.
01:08:47.080 And so smaller and smaller companies, which means it's shifting more to venture type investing and
01:08:52.920 biotech investing is taking that early stage one, early stage two risk, at which point pharma brings
01:08:59.640 in for the huge capital allocation required for late stage two and stage three approval that gets
01:09:07.520 the drug approval, which then gets to the point you raised, which is you've got these two drugs that
01:09:13.320 have been off patent for since Moses was throwing tablets at people. What are you going to do with it?
01:09:18.480 Well, you could keep selling them for $5,000 or you could repurpose them and increase by nearly 10x.
01:09:26.220 And I know that it sounds egregious. I don't have an answer though, because I don't really,
01:09:32.260 like this is almost to me a question of economics is the answer that all of this stuff has to be done
01:09:36.440 publicly so that shareholder value is no longer the thing that's being optimized for. Because as long
01:09:44.220 as these companies have to answer to shareholders, I don't think they'll ever figure out a way to put
01:09:50.720 the woman with breast cancer who's going to go bankrupt ahead of their shareholder. As awful
01:09:55.940 as that sounds, I think they're always going to say, I have a fiduciary responsibility to my
01:10:00.800 shareholder and that is to maximize the price. And I do think the government is doing a better job
01:10:06.300 at catching the most egregious examples of company that are grossly exploiting this.
01:10:10.980 But in the end, is Keytruda really worth what it's being charged today? I don't know how to
01:10:18.420 answer that question. I really have no clue how to answer that question. And you've more eloquently
01:10:23.720 than me said, every life is valuable and that includes the lives that remain, which I think is
01:10:30.140 a very important point. That's the counterpoint that's never made. It's not just the life of the
01:10:34.800 individual that we're debating extending by 3.1 months at some unbelievable sum. It's the lives
01:10:41.940 of everybody that remains and what it says about their social security check and what it says about
01:10:47.620 their schools and what it says about their healthcare. Wait, I want to answer this. If you
01:10:53.500 take a living frog and you throw it in boiling water, it will jump out. But if you put it in cold
01:11:00.820 water and start heating it slowly, it will die in that because it has been desensitized so slowly.
01:11:08.940 We began all these things with good intensity. That's what I keep saying to you over and over.
01:11:15.360 Some of the saddest things to me are this. 95% drugs we bring to the website fail. Why? Because
01:11:22.820 the pre-testing platforms we are using are so artificial. We are taking a very complex disease
01:11:30.960 like cancer and we are trying to reduce it by reductionist approaches into trying to replicate
01:11:38.620 this complexity in mouse models, in tissue culture, cell lines. And if those don't work,
01:11:45.220 we add layers upon layers of complexity to it by generic engineering, immune compromisation of the
01:11:53.340 animal. You know, after reading my book, The First Cell, a young woman wrote to me saying,
01:12:00.780 Dr. Raza, I'm a PhD student. I'm working on this cell line model of breast cancer, testing drugs against
01:12:10.280 it, but using a two and three dimensional in vitro system. And once this is successful,
01:12:19.220 that the drugs work against the cell lines, then I will go to the mouse model. And if that works,
01:12:25.580 then I have to go to human. But reading your book, I realized that it's all a waste of time. What should
01:12:30.620 I do? Is this even something I should spend the next 10 years of my life doing? So, but 90% of
01:12:40.200 research is still funding things, research dollars. You are talking about NCI dollars. What are the
01:12:45.560 funding for God's sake? The same old, same old ancient platforms which have shown a 95% failure
01:12:53.280 rate and the 5% success is ludicrous. Secondly, before you go, can you say more about that? Actually,
01:13:00.760 I'm glad you brought this up because I sometimes forget that I know a lot of the things you're
01:13:05.360 talking about and I take them for granted, but I think this is worth a bit of a detour if you don't
01:13:09.740 mind. Explain to people what that PhD student was doing. What is a day in the life for her or what is
01:13:17.100 she going to spend years doing? And how does that sort of model fall short? I think you can explain
01:13:24.820 it better than me because you have spent so much time in Dr. Rosenberg's lab, but very simply stated
01:13:30.820 when we want to try and find new drugs for cancer. We can't give drugs directly to humans. So we try to
01:13:38.040 first give them to something in our lab. What should that something be? Well, it started by taking
01:13:44.760 patients' tumor cells, but they don't last very long in our cultures, in the lab. So then that becomes a
01:13:51.680 problem. How should we perpetuate these cells in culture? By serendipity, some cancer cells began
01:14:00.080 to grow in the labs. And one of the first was the famous Hela cells from a patient with cervical cancer.
01:14:08.700 And these cells grew so well that they became immortalized. They self-perpetuated. They can be
01:14:15.080 grown from flask to flask, transferred from lab to lab. They can be put into mice and grow.
01:14:21.680 And so all this reproducible system that became available is called a tissue culture cell line.
01:14:28.960 And we learned with time to make more and more of these. So you make a pancreatic cancer now,
01:14:35.280 just like the Hela cells with cervical cancer. You take an ovarian cancer, a pancreatic cancer,
01:14:40.740 you grow them, and one of them will by chance mutate enough to become immortalized and then become
01:14:47.560 a tissue culture line. Now you can test drugs against it. But one of the first things that
01:14:53.600 I have written in my book in the first chapter is that by using these cell lines, when it was tested
01:15:01.760 to see what kind of genes are they expressing, it turns out that instead of expressing genes that were
01:15:09.620 faithful to the tissue of origin from which they came, for example, an ovarian cancer cell line
01:15:16.180 should be expressing genes that are expressed in ovarian cancer. Pancreatic cancer cell lines should
01:15:22.540 be expressing pancreatic genes. Instead, it turned out that there has been a transcriptomic drift
01:15:30.260 that basically all the cell lines, irrespective of their tissue of origin, express similar genes that
01:15:39.460 make them survivable under adverse in vitro conditions.
01:15:44.820 So let me explain one other thing for the listener here, which kind of ties in another
01:15:49.480 theme of yours, which is, because when you go back to what we learned in the Great War,
01:15:55.180 killing cancer cells is easy. I've had guests on this podcast before who have eloquently stated,
01:16:00.820 there's no one sitting in a home right now that doesn't already have 30 chemicals under their sink
01:16:05.780 that will kill every cancer, including the most devastating cancer like the one that killed
01:16:12.640 Andrew. The challenge is killing cancer and not killing everything else. And so now when you fast
01:16:20.040 forward to what you just said, when you have immortalized in vitro cultures that have become so
01:16:28.020 genetically skewed that they no longer actually represent a human cancer, you will learn a lot
01:16:36.540 about what it takes to kill them and not kill them. It just won't be relevant to the species of
01:16:42.680 interest, which is a human being. This is why I read the Oscar Wilde thing to you, that all men kill
01:16:49.560 the things they love. We started with a good thing. When it didn't correspond to what we were
01:16:55.360 hypothesizing, instead of changing our concept, we keep tinkering with trying to change the other
01:17:01.960 thing. This is exactly how you kill whatever you started out with. And you know what's worse, Peter,
01:17:10.180 is that 90%, 9-0, I want the audience to hear this clearly, 90% of the papers published in the highest
01:17:21.560 profile journals of science are irreproducible. I didn't know it was that high. It's still that
01:17:28.900 high. Up to 90%. Different studies, some show 30%, some 80%, some 90%. It is unconscionable what we are
01:17:39.920 doing. Why are they not reproducible? Because for the same reason, one set of mice don't correspond to
01:17:47.060 another set of mice in another lab. So the point I'm making is 95% of your drugs are failing until
01:17:54.700 now, after quarter of a trillion dollars in research, like you said, that is between $6 billion a year
01:18:03.140 right now, NCI funding, and another $6 billion from philanthropic funding. Where is all this $12 billion
01:18:10.400 going? And then breast cancer alone raises $6 billion in funding. And what are they doing?
01:18:17.320 Studying breast cancer cell lines against drugs. Yes, it will get that young lady a PhD eventually,
01:18:25.040 and then she will try to get grants. Eventually, she'll get fed up and go to industry. And I must
01:18:31.180 take exception with you condemning the industry. They are the easy target, pharma companies.
01:18:36.760 They are the easiest target. But the system of research and development in America is that
01:18:44.460 somebody like me, who is an academic researcher, will write a grant to NCI. They will fund me for
01:18:51.480 $250,000 a year for three to five years if I'm lucky. But let's put that in perspective, by the way.
01:18:59.620 By NCI standards, that's a lot. An RO1 at this point, what is an RO1 down to now? Is it down to
01:19:06.520 $450,000 a year for four to five years? Yeah.
01:19:10.360 That's almost as big a grant as someone's going to get.
01:19:13.460 Yes. And with that, all you can do is study one gene, one signaling pathway. But let's say
01:19:19.340 I luck out and I find something which I think is looking very encouraging and is a potential target.
01:19:26.580 The next step is obviously to take it to the bedside. But to do that, I have to now test this
01:19:32.160 in mouse models first, in two mammals, in fact, and then to take it to the bedside for a phase
01:19:38.360 one trial alone will cost $30 million. And by the time this drug will get approved, it will be $2.5
01:19:44.980 billion. Nobody can fund that kind of work except industry. It's a very strange kind of thing where
01:19:52.360 we are strange bedfellows, academics and industry. Academics will develop the biologic insights which
01:19:59.300 are needed to identify targets, but we don't have the bandwidth to take it to the patient. So industry
01:20:05.100 comes in, takes that, but then they have to bring it back to academics because that's where the
01:20:10.420 universities will help a co-patient. So do you today, the criterion for recruiting young faculty,
01:20:19.780 the young faculty is complaining to me that Dr. Raza, all the universities where we are applying,
01:20:26.240 ask us for it, how many clinical trials are you going to open when you come?
01:20:31.500 Yeah, look, it's a symptom of a broader issue, which is the incentives have come out of line.
01:20:38.240 I don't know how to fix that, by the way, but even taking it one step further, look,
01:20:42.380 just the entire system of publishing in academics has become so skewed because you took a good idea,
01:20:50.140 which was, wouldn't it be great if scientists would do work, would publish them in journals,
01:20:55.720 would have them peer reviewed, would share knowledge broadly so that others might see it,
01:21:00.800 learn from it and not make the same mistakes and build on the work of others, right? A beautiful
01:21:05.420 idea. You can't disagree with any of it. And by the way, recheck things that have been done to make
01:21:10.840 sure they were done correctly because under different conditions, we want to make sure they're
01:21:14.100 reproducible. Okay. Understandably then that idea gets extended into, this should be a criteria for
01:21:20.780 promotion within the academic system, which invariably turns into an entire cottage industry
01:21:27.500 of garbage journals and garbage study and garbage publications, which are driving up the fraction of
01:21:35.620 studies, which can't be reproduced. And by the way, the fraction of studies that can't even get cited,
01:21:41.680 they're so insignificant. And so you sort of think, my God, if something as pure and ideal as scientific
01:21:50.420 research and publishing has become so difficult to do, and I don't have a great solution for that.
01:21:58.420 The process you're describing is a logarithmic order in front of that, which is taking research
01:22:06.200 from the so-called bench to the bedside. That's the thing that I still don't, even after reading
01:22:13.940 about this topic and not just your book, but other books, I still don't have a great sense of what the
01:22:21.000 future looks like. I don't disagree that the water is starting to get uncomfortably warm here as a
01:22:26.180 little frog. And I don't disagree that we need to get out of this bath of water and into a cooler bath
01:22:32.540 of water. But boy, I have to be honest with you, I'm discouraged. No, no, don't be. I have a
01:22:38.420 solution for us and a very important solution. You know, Peter DeRice is a writer who wrote a book in
01:22:45.800 1961. He wrote a novel because his own daughter, who was 10 or 11, died of leukemia in his arms and
01:22:55.080 after a horrible battle. In 1961, Peter, DeRice says, so the treatment for leukemia today
01:23:05.940 is a local rather than an express train. Same run, a few more stops. But that's how medicine functions,
01:23:16.940 perfecting the art of prolonging disease. This was in 1961. How is this different? The run for
01:23:27.760 leukemia is still a local. What I want to say is I feel like I'm living in a theater of the absurd.
01:23:36.020 Why aren't other people seeing the spectacular failures we are dealing with? And why do we keep
01:23:43.720 mollycoddling the public? Why do we keep promoting the two, three months or five months advantage in
01:23:51.440 survival? Why aren't we going for bigger goals and better things? We can do it. You know how we can do
01:24:00.200 it is very simple. What has worked in cancer until now? Early detection. How is it that we are living
01:24:08.700 in an era of the most sophisticated technologic advances possible? And yet the treatment of cancer
01:24:17.720 is paleolithic. It belongs in the Stone Age in the caves. Giving the kind of disfiguring, horrible
01:24:27.440 treatments we give is like beating, someone said this, beating the dog with a baseball bat to get rid of
01:24:34.980 its fleas. Have you ever seen somebody being treated with CAR-T therapy? My God, there are whole industries
01:24:41.560 sprouting up to control the side effects. Why are we even developing such terrible therapies? Yes, we
01:24:49.960 should develop them, but they should be used when the tumor burden is not that high. So once again, I want
01:24:56.220 to be very clear about a couple of things before I give you my solution. Number one, I'm not against
01:25:02.900 animal research at all. For biology, it is very important to use the animal model. All I'm against
01:25:11.960 is drug development in animals because what you learn in animals by using drugs is only correct for
01:25:20.440 animals. It does not automatically extrapolate to humans. So just to be clear, you're saying you would
01:25:28.080 still use animals for safety, but you would disregard them for efficacy? I would not use them
01:25:34.300 for safety either. Why should it give me any level of confidence that the drug didn't kill mouse, it
01:25:40.200 wouldn't kill a human? It is very little to do with each other. We don't have to go into it now, but I
01:25:46.080 guess, do you know from sort of even back of the envelope how that would change the regulatory landscape
01:25:52.260 if we now had to go to a much earlier phase one in humans? Obviously, probably using a milder dose
01:25:59.280 escalation, or would you be talking about doing primates instead? What is the actual model?
01:26:05.040 None of those. In fact, the FDA has a system which is called phase zero, in which you don't just bypass
01:26:13.360 any animals, you use one five hundredth of the dose, starting dose in humans, and work your way up
01:26:21.280 that. So basically, it's homeopathic all the way up. Yeah. So that's how you do it with a phase zero
01:26:27.680 trial. What I'm saying is, look, the only thing that has worked is early detection. We have great
01:26:33.720 technology available. We shouldn't be talking about early detection doesn't work because mammograms have
01:26:39.720 not been helpful or PSA have led to overdiagnosis and men undergoing very macabre surgeries and things.
01:26:47.180 No, all I'm saying is that we should definitely take advantage of the cutting edge genomics, transcriptomics,
01:26:55.700 proteomics, metabolomics, the scanning and imaging devices that have been developed and use artificial
01:27:02.400 intelligence to put all this together. Develop 50 tests if we have to, to identify biomarkers,
01:27:09.120 which are based on all these things and combine them with the latest technology to try and start
01:27:17.660 monitoring the human body, not once a year, but continuously like a machine. And how do you do that?
01:27:24.940 Well, you see this chip. You can see it. The audience cannot. It's a small chip, the M chip. You can look it up
01:27:31.960 because it is FDA approved. It is based on microfluidics. You put one drop of blood here,
01:27:37.620 which goes through microfluidics and interacts with the biomarker put here. The biomarker in M chip's
01:27:44.300 case, which is FDA approved is PSA. So men who have been diagnosed with a high PSA can use this chip.
01:27:52.960 It can slide into a small device and very soon into your cell phone and give you your PSA four times a
01:27:58.960 day if you want to see it. And if you're diagnosed with having a high PSA, you don't have to go in
01:28:04.640 and have a complete abdominal resection with the removal of every lymph node and be eviscerated. No,
01:28:13.180 you follow this at home if you have to as often as you want. I'm saying that if we develop a biomarker
01:28:20.680 that is identifying the earliest footprints of a pancreatic cancer, we put that next in the next lane.
01:28:27.620 And for ovarian cancer in the next door, for each cancer, we develop like a barcode
01:28:33.300 and with one drop of blood. So Toshiba, a company just announced that they can detect 13 different
01:28:41.300 cancers from one drop of blood in four hours for $180. There's a company in the Bay Area that I
01:28:48.660 follow very closely called Grail, and they're doing something very similar. At this point,
01:28:54.100 they're, you know, in phase two with probably almost 30 different cancers. I agree with you
01:29:00.880 completely. I mean, my view of cancer is rule number one is don't get it. I mean, that sounds
01:29:06.480 glib, but I don't think enough attention is paid to the don't get it rule, which is why aren't we
01:29:12.060 trying to better understand what the environmental triggers of cancer are? Because while, as you point
01:29:18.080 out, it has always been with us, I think there is reasonable enough evidence to suggest that its
01:29:23.900 incidence is higher in a modern world than in a non-modern world. And therefore, what is it about
01:29:29.840 a modern world? For example, what is it about our diet or about our stress or our lack of exercise
01:29:35.840 that could be amplifying our risk? And if you think about it, if changing factors of our lifestyle
01:29:42.420 could reduce your risk of cancer by 30 to 50%, which my reading of the literature says is absolutely
01:29:50.240 the case, how could we not make that a high priority to understand? And when you pair the
01:29:58.000 rule number one, don't get cancer, with rule number two, very smart screening for cancer, you then get
01:30:06.200 into rule number three, which is if you get cancer, treat it so early, treat it when it is basically
01:30:13.060 in the millions rather than the billions of cells. And for someone who might not have the familiarity
01:30:19.240 with cells, a million cancer cells is not even detectable to the naked eye. A billion is. And so
01:30:26.000 there's a very big difference between when you can catch a million cancer cells versus a billion.
01:30:31.220 And I agree with you, by the way, completely that most people who are critics of early
01:30:35.980 screening are unfortunately lacking the nuance to appreciate the accepted failures of things like
01:30:44.900 PSA and mammography, which I won't go into here. I've covered them in great detail in some other
01:30:50.620 podcasts too. In particular, I'll just direct the listener to, I think the failures of PSA stand alone
01:30:57.040 as a failure has been covered very well in the podcast with Ted Schaefer. And Ted talks very eloquently
01:31:03.580 about how if you are wed to PSA using PSA volume, where you take PSA normalized to prostate volume and
01:31:10.860 PSA velocity, which Ezra, you would get out of what you propose, which is the rate of change of PSA over
01:31:18.160 time. So PSA has a rate of change called PSA velocity, PSA volume become much better indicators
01:31:25.040 of prostate cancer risk than just PSA. But also you go far beyond PSA to things like 4K and other types
01:31:32.660 tests that add more nuance to this. I think the story becomes much more clear that this type of
01:31:38.940 early detection matters. And I think as it pertains to the limitations of mammography, I would direct
01:31:45.000 people to the podcast I did with Raj Atariwala, where we talked about cancer screening. And we actually
01:31:53.300 very specifically addressed some of the limitations of the literature on these isolated techniques like
01:31:59.420 mammography. So you're not going to get any disagreement out of me on both of those fronts.
01:32:05.040 So I guess the question is, do we really believe that by taking those types of steps, we will reduce
01:32:14.340 the need for the cancers for which we have just not had the big breakthroughs, which is basically
01:32:22.160 lung, pancreas, prostate, breast, colon, and GBM. Those are basically the most lethal cancers.
01:32:31.720 Outside of GBM, it's the metastatic versions of the others. Obviously GBM doesn't leave the brain,
01:32:36.580 it kills locally. That's got to be two thirds of cancer deaths. And you're basically saying,
01:32:43.860 we have to catch these things long before they're ever in a position to leave the primary organ and not
01:32:49.280 try to reinvent the onc drug discovery wheel coming up with another cocktail that's going to be as
01:32:57.860 lucky as we were with Hodgkin's lymphoma. Is that, I don't want to put words in your mouth, but is that
01:33:02.480 your view? Yeah. Well, sort of, but let me restate what specifically I feel. First of all, about the
01:33:11.220 lifestyle you're talking about. Of course, lifestyle is, it's only common sense that if you smoke,
01:33:16.920 it's not going to be good for you, your likelihood of getting not just lung cancer, but many diseases
01:33:23.180 will be high. So yes, lifestyle changes have, we have to continuously drill into our consciousness,
01:33:31.400 what is good for us and what is bad for us and try not to get it. The problem is that with cancer,
01:33:37.780 as I began by telling you, heredity and pathogens and environmental exposure like smoking, etc.,
01:33:45.320 do account for a certain percentage, the vast majority, there is no reason why they get cancer.
01:33:51.420 We, at least a reason that we can identify yet. I think that's the challenge is that with smoking,
01:33:57.960 the difference between the people who smoked and the people who didn't smoke was so great that it was
01:34:04.420 appreciable. But you're right with most other environmental contributors, with maybe the only
01:34:11.020 other exception being obesity, it's very difficult to tease out what else could be contributing. For
01:34:18.340 example, I don't know if you're running or the trampoline is making enough of a difference
01:34:25.280 because it's very difficult to study that longitudinally and prospectively. And secondly,
01:34:31.240 I don't know that enough people are doing it and it would create a big enough signal that we can
01:34:35.920 measure it. Well, that's what I was going to say. We don't even know whether eggs are good or bad for
01:34:41.480 you to this day. So those are the kinds of issues with lifestyle large studies. Now, the point I'm trying
01:34:47.740 to make, though, is slightly different. A lot of people smoke. Not all of them get cancer. So there are
01:34:54.020 other co-factors that exist. All these things have to be worked out. Haven't we been trying for a hundred
01:34:59.740 years? For God's sake, don't. The investigators who act like this is something they have discovered
01:35:05.300 today to be looked at. No, this is what we have been trying to do forever. It's not that simple.
01:35:12.220 What we are finding is that for the vast majority of cancers, their random mutations account for it,
01:35:19.260 which means that cancer is most common with age, increasing age. Why? Because with age, many more of
01:35:27.140 the cells in our body have undergone several divisions. And with each division, we pick up
01:35:32.860 some DNA copying errors, two to three on an average. So by the time our cell is now from birth to like
01:35:40.440 60 years of age, every cell has undergone multiple cycles of proliferation. Therefore, multiple gene
01:35:47.560 genetic mutations have collected. And these are making the cell susceptible that now it's like dropping
01:35:55.000 grains of sand and they will form a pile. And at one grain of sand, which is no different than millions
01:36:01.760 before that had gone before, it will suddenly cause an avalanche and the pile will collapse.
01:36:08.180 Not because the last grain of sand was different, but the pile had become unstable. So with age,
01:36:14.180 the body becomes unstable because all the cells have these kinds of mutations. So, and not only that,
01:36:20.260 metabolism can go wrong. And sometimes as shown by whole genome sequencing of over 2000 tumors,
01:36:27.180 that there are a few cancers where no mutations were found in advanced cancers. So how did that
01:36:33.600 happen? Well, because sometimes it is the disturbed metabolism that then leads to production of reduced
01:36:42.580 oxygen species or free radicals, for example, that go and chop up and cause mutations and that genetic
01:36:48.740 mutations are a secondary event. The primary event is a metabolic disturbance. So, I mean, all this needs
01:36:55.180 to be done, all this needs to be studied. And it isn't like it hasn't been studied. Since 1921,
01:37:02.080 poor Otto Warburg made the first observation of anaerobic metabolism. And since I was doing ketogenic
01:37:09.160 type diets in the 1980s. So please don't think that any of these things are new. But the question that I am
01:37:18.000 asking as someone who's been in this field for 43 years now is this, if I'm still using seven and three
01:37:26.300 to treat AML and for most common cancers, we are still using slash poison and burn. It is not for lack
01:37:34.040 of resources. It is not for lack of very, very smart people, hundreds of thousands of them who are
01:37:40.640 working 16 hours a day to try and find the answer. But the answer is very complicated. It has too many aspects
01:37:48.980 to it. So the only thing we should do is I am beseeching to everybody in cancer related fields, let's just spend
01:37:59.000 a little more effort, a little more resources in earlier detection. Yes, keep trying to understand metabolic
01:38:06.440 pathways and intracellular signaling and checkpoints and CAR T's and everything else. But instead of
01:38:13.200 spending 5% in prevention, let's spend 50% in prevention and early detection. That is all I'm
01:38:20.600 asking for. So a lot of people have asked me, Peter, because I've been completely uncompromising in
01:38:28.360 my criticism, as you've heard now, I am completely merciless. You know why? Because I have brought the
01:38:35.160 patient back front and center and everything I look at is through patients' human anguish.
01:38:42.160 Our problem is that 90% of our researchers never see a cancer patient because they are basic scientists
01:38:48.840 and they study tumors that they grow on their own in their labs. So they don't see a disease they are
01:38:56.460 trying to develop treatment for and they are using animals who don't get these diseases spontaneously.
01:39:02.960 How artificial can you become, for God's sake? So my thing is, while you're doing all that,
01:39:10.520 at least let's employ all of the sophisticated technology and a lot of the intellectual resources
01:39:16.480 to developing biomarkers for early detection. Why not look at every compartment, whether it's blood,
01:39:24.460 sweat, tears, saliva, urine, microbiome, study everything but human. Stop studying animals,
01:39:31.840 for God's sake. Study new issue. You're making so much sense to me that I'm struggling to come up
01:39:37.300 with a counter-argument to that point you're making. I mean, should 50% of our resources be put
01:39:43.840 into prevention and early detection rather than 4% if that? Absolutely. Should we also shift this to
01:39:53.360 study disproportionately in the study of interest? I couldn't agree with you more.
01:39:58.040 You made a point a moment ago about the nature of contact. I wanted to use that as a point to come
01:40:06.460 back to Omar. Why did you include the story of Omar in your book? He's not unique, right? I mean,
01:40:13.120 you've treated a million Omars. What was it about him that spoke to you so much? It had to be more than
01:40:19.660 just his ethnicity, but I don't know. Maybe I shouldn't assume that.
01:40:23.400 Well, first of all, he's my best friend's son. Here is a 38-year-old young man, a graduate of
01:40:32.180 Oxford and Columbia. His teaching has finally fallen in love, calls his parents to come and get him
01:40:39.820 engaged. And when they arrive, the young couple, he has a little osteogenic sarcoma. So the thing that
01:40:47.920 has forced that made me put Omar into the book is the utter helplessness of oncologists because from
01:40:56.240 day one, when you have not resected that solid tumor completely, you were a surgeon, you were a
01:41:03.720 surgical oncologist, you are a surgeon. You know this, Peter. If you leave behind 10% of the tumor or
01:41:11.240 even your microscopic pathology shows that cancer cells have entered blood vessels, as was the case
01:41:18.500 with Omar. Now you know that his chances of survival beyond a few couple of years at most are 0.00.
01:41:27.200 What are your choices you are going to give to Omar? Either you die of cancer or you die of the
01:41:32.840 treatment we are going to give you. Because the problem is if we don't give treatment, then death
01:41:38.440 from cancer is horrendous in itself. It's one of the most painful deaths. So are we at least doing
01:41:45.900 some palliation? And Omar's case was really huge. It's a good question you asked. It was emotionally
01:41:54.200 soul destroying to see this young man who's already just embarking on his career. Finally, after years
01:42:01.960 and years of hard work, has met the woman, he gets married a couple of months after the diagnosis
01:42:08.260 actually, and knowing that he's going to die. And I had to live through every single day, not just in
01:42:16.600 the hospital, but also at home because we are seeing him. And by the way, if I recall, this was only
01:42:23.000 about five years after your husband died, yes? No longer. Harvey died in 2002. Omar dies in 2009.
01:42:30.240 Okay. Okay. Sorry. But yeah. Yes. Yeah. Not that far. So I think also in the book, I tried to balance
01:42:37.420 it out by presenting some elderly people like Lady N, Kitty C are older. Harvey was older, whereas JC,
01:42:46.100 Andrew and Omar, the three are younger people. So, and different types of cancers I also wanted to show.
01:42:52.280 So brain tumor, osteogenic sarcoma and a liquid tumor. Then Harvey had a lymphoma.
01:42:58.020 Many people ask me because I have been so brutal in my criticism of everybody. And that's why I began
01:43:06.440 telling you that, please, let's not just blame pharma companies. The hospitals who are supposed to be
01:43:12.020 non-profit hospitals are making so many hundreds of millions of dollars in profits. What should they do?
01:43:17.860 They have no shareholders to distribute it to. So they give large raises to their bureaucracy,
01:43:24.880 the executive business people running the hospital, and then they start buying other hospitals and start
01:43:31.600 investing in brick and mortar. This is what's happening. I, in fact, think about healthcare very much.
01:43:38.360 I was talking to Perry Marshall the other day, who was talking about higher education, that in the
01:43:43.760 post-COVID world, one of the things that will be completely redone is higher education, because the
01:43:50.120 two variables who have skin in the game in higher education are students and teachers. And students
01:43:57.280 are embroiled in horrible loans by the time they graduate. And teachers are not even hired in permanent
01:44:04.220 positions anymore. There are adjunct professors that are hired. So you don't have to give them any kinds
01:44:09.820 of benefits. And those two people who have skin in the game suffer, whereas universities are
01:44:15.720 developing endowments in billions of dollars. These are academic institutions. But I compare that
01:44:21.740 same thing to healthcare. The two people with skin in the game in healthcare are patients and doctors.
01:44:27.400 Patients are fleeced for every last penny, and doctors are overworked all the time. So we have no time
01:44:33.860 to spend. And businessmen are running the whole show. So I think the system has, it's like that frog
01:44:40.260 analogy over and over again. No one is going to give up what they're doing willingly at all. I believe
01:44:46.800 exactly what Thomas Kuhn said. If you want to change the paradigm, you have to show a better one. That's it.
01:44:53.120 So how do we show a better paradigm? Well, at least I'm pointing to the only successful strategy in
01:44:59.560 cancer is early detection. Why not use the latest technology to go for early detection?
01:45:06.140 We can financially incentivize it. And with the one success, the whole field can turn around because
01:45:12.320 they will see that that's where it's a better thing to invest rather than in a venture that has a 95%
01:45:19.820 rate of failure. And mark my words, the coming decade of 2020 to 2030, we'll see this shift from treating
01:45:28.420 the disease to trying to detect early and prevent the disease from becoming established.
01:45:35.500 I agree with you. I really do agree with you. I don't know that I can speak convincingly to the
01:45:41.400 timeframe, but I am actually very optimistic with the potential of liquid biopsies. And it's something
01:45:48.000 we have been very eager. It's been a big part of our practice, frankly, inside of our practice.
01:45:54.740 And I look forward to having a more rigorous discussion about this that's dedicated on the
01:45:59.880 podcast. Once some of the technologies get through certain stages of FDA.
01:46:03.900 Ezra, I want to close with a question about the loss of your husband. At any point during that ordeal,
01:46:11.200 when he was struggling and you were right there with him and you had this young daughter,
01:46:17.480 was there any point of view that was thinking, this is so unfair,
01:46:21.280 the disease that you've devoted your life to, the disease that he has devoted his life to is
01:46:27.280 ultimately the disease that's going to take him and not just take him, but take him decades too soon.
01:46:33.160 Or were you able to sort of come to this place of what some might call radical acceptance of just
01:46:38.600 saying, I accept what I can change. I have the courage to fight the things that I can. And I have
01:46:45.100 the courage to know the distinction, the so-called serenity prayer. How did you go through that at such
01:46:50.140 a young age? It's very hard to describe what one goes through. Of course, I kick doors all the time
01:46:58.800 and I had crying fits all the time. And I remember calling my mother so often on weekends we used to
01:47:05.540 talk. She was in Karachi, of course. And I would say so many of my friends hate their husbands
01:47:10.180 and they're doing fine. And look at me. I'm one who's crazy about Harvey and he's dying in front of
01:47:17.620 my eyes. I went through every human emotion that a wife would go through, especially because our
01:47:24.280 daughter was so little. And Harvey is the one who actually had reached the point of acceptance. And
01:47:30.220 when I would lose it every now and then in front of him, he would very calmly tell me not to worry
01:47:35.620 about it. It's just the luck of the draw as don't worry. And he would one time he said, look, when he
01:47:42.040 was diagnosed, he was initially told his diagnosis. His reaction was so quintessential Harvey. He said,
01:47:50.680 well, I'm glad it's me and not you or Shahrazad. This I can handle that I couldn't. And so when you're
01:47:59.400 going through something like caring for someone who you love, but who has made you responsible for
01:48:07.580 every decision as well, I'll also end by quoting my favorite Dickinson again, which is what one has
01:48:16.080 to do. I had no time to hate because the grave would hinder me. And life was not so ample I could
01:48:27.980 finish enmity. Nor had I time to love. But since some industry must be, this little toil of love I
01:48:41.480 thought was large enough for me.
01:48:48.000 That's a treat I don't get often. And the listeners, I think, will agree that it's not every day you tune
01:48:53.040 into a podcast where you get treated to both the sort of the literary sprinklings of greatness coupled
01:49:00.220 with a, you know, a difficult but a very important discussion about a disease that is going to touch
01:49:05.840 anybody listening to this. Because if we're fortunate enough to not be the ones who get it, we are going
01:49:11.780 to know somebody who does. It is tragically that ubiquitous a disease. I want to thank you for your time
01:49:18.840 today. And I want to thank you for the work you've put into this. And finally, your patience. It has
01:49:25.940 taken far too long to get this interview on the books. And I hope that the listeners will at least
01:49:32.800 agree it was worth the wait. Well, before we end, Peter, I do want to say that since 1984, as a result of
01:49:40.720 my experience with a patient, I started saving samples on them. So blood and bone marrow biopsies
01:49:49.840 and aspirates and two germline controls, T cells and buccal smears, seven different types of cells like
01:49:57.900 CD34 separation, neutrophil separated, mononuclear cell separated, all kinds of elaborate things.
01:50:04.640 And today, this tissue repository has over 60,000 samples from thousands of patients who have been
01:50:12.360 serially followed for years, some of them. And not a single cell comes from a second oncologist.
01:50:21.440 To this day, I do all the bone marrows with my own hands. So this tissue repository, which contains
01:50:28.360 samples of all sorts, following the natural history of diseases in patients as they progress from a pre-
01:50:36.640 leukemia to acute leukemia, is a national treasure. It's a repository which can really unravel so much and
01:50:46.560 trace back to the cell of origin, the first cell, find the biomarkers that are associated with a pre-
01:50:55.360 leukemia that spiraled out of control into acute leukemia within months compared to one that took
01:51:01.780 15 years to become one. I think that I want to end by saying in a very positive way that I am
01:51:11.480 extremely optimistic about the future, even though we spent most of our time in talking about very
01:51:17.980 negative and very depressing, pessimistic review of what the field has been.
01:51:23.700 The future looks extremely bright and I am so happy that I have collected all this tissue,
01:51:31.120 which can now be used in the service of our patients who went through severe pain and anguish
01:51:38.020 while donating these samples. We have now, the technology has developed and hopefully the resources
01:51:45.020 will be there to finally study the whole tissue repository properly and find that first cell.
01:51:51.920 Thank you so much for the time you have given me today, Peter.
01:51:55.880 I wish you the best as you remain in quarantine. I wish you a safe re-entry in New York when the time
01:52:01.720 comes. Thank you.
01:52:03.380 Thank you for listening to this week's episode of The Drive. If you're interested in diving deeper
01:52:08.860 into any topics we discuss, we've created a membership program that allows us to bring you
01:52:13.280 more in-depth exclusive content without relying on paid ads. It's our goal to ensure members get back
01:52:19.060 much more than the price of the subscription. Now to that end, membership benefits include a bunch of
01:52:24.380 things. One, totally kick-ass comprehensive podcast show notes that detail every topic, paper,
01:52:29.980 person thing we discuss on each episode. The word on the street is nobody's show notes rival these
01:52:35.400 monthly AMA episodes or ask me anything episodes, hearing these episodes completely access to our
01:52:42.060 private podcast feed that allows you to hear everything without having to listen to spiels like
01:52:46.960 this. The qualities, which are a super short podcast, typically less than five minutes that we
01:52:52.320 release every Tuesday through Friday, highlighting the best questions, topics, and tactics discussed on
01:52:57.140 previous episodes of The Drive. This is a great way to catch up on previous episodes without having
01:53:02.480 to go back and necessarily listen to everyone. Steep discounts on products that I believe in, but for
01:53:08.380 which I'm not getting paid to endorse, and a whole bunch of other benefits that we continue to trickle in
01:53:13.360 as time goes on. If you want to learn more and access these member-only benefits, you can head over
01:53:17.820 to peteratiamd.com forward slash subscribe. You can find me on Twitter, Instagram, and Facebook,
01:53:25.020 all with the ID peteratiamd. You can also leave us a review on Apple Podcasts or whatever podcast
01:53:31.520 player you listen on. This podcast is for general informational purposes only and does not constitute
01:53:37.080 the practice of medicine, nursing, or other professional healthcare services, including the giving of
01:53:42.580 medical advice. No doctor-patient relationship is formed. The use of this information and the
01:53:48.280 materials linked to this podcast is at the user's own risk. The content on this podcast is not intended
01:53:54.460 to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard
01:54:00.940 or delay in obtaining medical advice from any medical condition they have, and they should seek the
01:54:07.100 assistance of their healthcare professionals for any such conditions. Finally, I take conflict
01:54:12.560 of interest very seriously. For all of my disclosures and the companies I invest in or advise,
01:54:18.300 please visit peteratiamd.com forward slash about where I keep an up-to-date and active list of such companies.
01:54:42.560 Thank you.